Growth Metrics

Rockwell Medical (RMTI) Net Income towards Common Stockholders (2016 - 2026)

Rockwell Medical filings provide 16 years of Net Income towards Common Stockholders readings, the most recent being -$640000.0 for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 17.84% to -$640000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.6 million, a 907.4% decrease, with the full-year FY2025 number at -$5.6 million, down 907.4% from a year prior.
  • Net Income towards Common Stockholders hit -$640000.0 in Q4 2025 for Rockwell Medical, up from -$1.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $1.7 million in Q3 2024 to a low of -$8.9 million in Q4 2021.
  • Median Net Income towards Common Stockholders over the past 5 years was -$2.0 million (2023), compared with a mean of -$3.3 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: surged 179.54% in 2024 and later tumbled 632.88% in 2025.
  • Rockwell Medical's Net Income towards Common Stockholders stood at -$8.9 million in 2021, then surged by 73.59% to -$2.4 million in 2022, then skyrocketed by 31.71% to -$1.6 million in 2023, then surged by 51.7% to -$779000.0 in 2024, then rose by 17.84% to -$640000.0 in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$640000.0 (Q4 2025), -$1.8 million (Q3 2025), and -$1.6 million (Q2 2025) per Business Quant data.